163 related articles for article (PubMed ID: 35347596)
1. Magnetic resonance elastography and proton density fat fraction predict adverse outcomes in hepatocellular carcinoma.
Hui RW; Chan AC; Lo G; Lo R; Chan C; Kotewall CN; Mak LY; She WH; Au KP; Ai V; Fung J; Yuen MF; Seto WK
Hepatol Int; 2022 Apr; 16(2):371-380. PubMed ID: 35347596
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging metrics and the predictability of adverse outcomes in on-treatment Asian chronic hepatitis B.
Hui RW; Chiu KW; Mak LY; Chang HC; Cheung KS; Fung J; Yuen MF; Seto WK
J Gastroenterol Hepatol; 2022 Jun; 37(6):1139-1147. PubMed ID: 35368120
[TBL] [Abstract][Full Text] [Related]
3. Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment.
Cho HJ; Kim B; Kim HJ; Huh J; Kim JK; Lee JH; Seo CW; Ahn HR; Eun JW; Kim SS; Cho SW; Cheong JY
Eur Radiol; 2020 Aug; 30(8):4182-4192. PubMed ID: 32189053
[TBL] [Abstract][Full Text] [Related]
4. Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection.
Marasco G; Colecchia A; Colli A; Ravaioli F; Casazza G; Bacchi Reggiani ML; Cucchetti A; Cescon M; Festi D
J Hepatol; 2019 Mar; 70(3):440-448. PubMed ID: 30389551
[TBL] [Abstract][Full Text] [Related]
5. Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality.
Lee SW; Huang DQ; Bettencourt R; Ajmera V; Tincopa M; Noureddin N; Amangurbanova M; Siddiqi H; Madamba E; Majzoub AM; Nayfeh T; Tamaki N; Izumi N; Nakajima A; Yoneda M; Idilman R; Gumussoy M; Oz DK; Erden A; Loomba R
Aliment Pharmacol Ther; 2024 Jan; 59(1):80-88. PubMed ID: 37968251
[TBL] [Abstract][Full Text] [Related]
6. Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease.
Petta S; Sebastiani G; Viganò M; Ampuero J; Wai-Sun Wong V; Boursier J; Berzigotti A; Bugianesi E; Fracanzani AL; Cammà C; Enea M; Grottes MD; Di Marco V; Younes R; Keyrouz A; Mazzola S; Mendoza Y; Pennisi G; Romero-Gomez M; Craxì A; de Ledinghen V
Clin Gastroenterol Hepatol; 2021 Apr; 19(4):806-815.e5. PubMed ID: 32621970
[TBL] [Abstract][Full Text] [Related]
7. MRI proton density fat fraction for estimation of tumor grade in steatotic hepatocellular carcinoma.
Kupczyk PA; Kurt D; Endler C; Luetkens JA; Kukuk GM; Fronhoffs F; Fischer HP; Attenberger UI; Pieper CC
Eur Radiol; 2023 Dec; 33(12):8974-8985. PubMed ID: 37368108
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional magnetic resonance elastography combining proton-density fat fraction precisely identifies metabolic dysfunction-associated steatohepatitis with significant fibrosis.
Lin H; Qiu S; Yang Y; Yang C; Shen Z; Chen Y; Zhang Z; Feng Y; Yan F
Magn Reson Imaging; 2023 Dec; 104():1-8. PubMed ID: 37553044
[TBL] [Abstract][Full Text] [Related]
9. [Transient elastography as a predictor of oesophageal varices in patients with liver cirrhosis].
Pár G; Trosits A; Pakodi F; Szabó I; Czimmer J; Illés A; Gódi S; Bajor J; Sarlós P; Kenyeres P; Miseta A; Vincze A; Pár A
Orv Hetil; 2014 Feb; 155(7):270-6. PubMed ID: 24509356
[TBL] [Abstract][Full Text] [Related]
10. MRI-AST (MAST) Score Accurately Predicts Major Adverse Liver Outcome, Hepatocellular Carcinoma, Liver Transplant, and Liver-Related Death.
Truong E; Gornbein JA; Yang JD; Noureddin N; Harrison SA; Alkhouri N; Noureddin M
Clin Gastroenterol Hepatol; 2023 Sep; 21(10):2570-2577.e1. PubMed ID: 36813013
[TBL] [Abstract][Full Text] [Related]
11. Non-Invasive Approaches to Estimate Liver Steatosis and Stiffness in Children With Non-Alcoholic Fatty Liver Disease.
Yodoshi T; Orkin S; Trout AT; Arce-Clachar AC; Bramlage K; Liu C; Fei L; Dillman JR; Xanthakos SA; Mouzaki M
J Pediatr Gastroenterol Nutr; 2022 Apr; 74(4):495-502. PubMed ID: 34908012
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib.
Jayakumar S; Middleton MS; Lawitz EJ; Mantry PS; Caldwell SH; Arnold H; Mae Diehl A; Ghalib R; Elkhashab M; Abdelmalek MF; Kowdley KV; Stephen Djedjos C; Xu R; Han L; Mani Subramanian G; Myers RP; Goodman ZD; Afdhal NH; Charlton MR; Sirlin CB; Loomba R
J Hepatol; 2019 Jan; 70(1):133-141. PubMed ID: 30291868
[TBL] [Abstract][Full Text] [Related]
13. Assessing Hepatic Fibrosis Using 2-D Shear Wave Elastography in Patients with Liver Tumors: A Prospective Single-Center Study.
Huang Z; Zheng W; Zhang YJ; Xu L; Chen JB; Chen JC; Chen MS; Zhou Z
Ultrasound Med Biol; 2017 Nov; 43(11):2522-2529. PubMed ID: 28807448
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance elastography-based prediction of hepatocellular carcinoma recurrence after curative resection.
Abe H; Midorikawa Y; Higaki T; Yamazaki S; Aramaki O; Nakayama H; Moriguchi M; Kanda T; Moriyama M; Okada M; Nishimaki H; Sugitani M; Tsuji S; Takayama T
Surgery; 2021 Jul; 170(1):167-172. PubMed ID: 33752906
[TBL] [Abstract][Full Text] [Related]
15. 3D MR Elastography of Hepatocellular Carcinomas as a Potential Biomarker for Predicting Tumor Recurrence.
Wang J; Shan Q; Liu Y; Yang H; Kuang S; He B; Zhang Y; Chen J; Zhang T; Glaser KJ; Zhu C; Chen J; Yin M; Venkatesh SK; Ehman RL
J Magn Reson Imaging; 2019 Mar; 49(3):719-730. PubMed ID: 30260529
[TBL] [Abstract][Full Text] [Related]
16. Occult cirrhosis diagnosed by transient elastography is a frequent and under-monitored clinical entity.
Chen T; Wong R; Wong P; Rollet-Kurhajec KC; Alshaalan R; Deschenes M; Ghali P; Sebastiani G
Liver Int; 2015 Oct; 35(10):2285-93. PubMed ID: 25676459
[TBL] [Abstract][Full Text] [Related]
17. Value of tumor stiffness measured with MR elastography for assessment of response of hepatocellular carcinoma to locoregional therapy.
Gordic S; Ayache JB; Kennedy P; Besa C; Wagner M; Bane O; Ehman RL; Kim E; Taouli B
Abdom Radiol (NY); 2017 Jun; 42(6):1685-1694. PubMed ID: 28154910
[TBL] [Abstract][Full Text] [Related]
18. Head-to-head comparison of magnetic resonance elastography-based liver stiffness, fat fraction, and T1 relaxation time in identifying at-risk NASH.
Li J; Lu X; Zhu Z; Kalutkiewicz KJ; Mounajjed T; Therneau TM; Venkatesh SK; Sui Y; Glaser KJ; Hoodeshenas S; Manduca A; Shah VH; Ehman RL; Allen AM; Yin M
Hepatology; 2023 Oct; 78(4):1200-1208. PubMed ID: 37080558
[TBL] [Abstract][Full Text] [Related]
19. Use of magnetic resonance elastography for assessing liver functional reserve: A clinical study.
Li B; Min J; Liang WR; Zhang GQ; Wu JJ; Jin K; Huang W; Ying CY; Chao M
World J Gastroenterol; 2015 Jun; 21(24):7522-8. PubMed ID: 26139999
[TBL] [Abstract][Full Text] [Related]
20. MR elastography of hepatocellular carcinoma: Correlation of tumor stiffness with histopathology features-Preliminary findings.
Thompson SM; Wang J; Chandan VS; Glaser KJ; Roberts LR; Ehman RL; Venkatesh SK
Magn Reson Imaging; 2017 Apr; 37():41-45. PubMed ID: 27845245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
